Having trouble finding Striverdi Respimat at your pharmacy? Here's why this COPD inhaler can be hard to locate and what you can do about it in 2026.
You've got your prescription in hand, you drive to the pharmacy, and you hear the words no one wants to hear: "We don't have that in stock." If you're looking for Striverdi Respimat (Olodaterol), this scenario might feel all too familiar.
Striverdi Respimat is a once-daily maintenance inhaler used to manage chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It's not a rescue inhaler — it's the kind of medication you use every day to keep your airways open and your breathing steady. So when you can't find it, it's more than an inconvenience. It can affect how well you manage your condition.
Let's break down why Striverdi can be hard to find and, more importantly, what you can do about it.
Striverdi Respimat is the brand name for Olodaterol, a long-acting beta2-adrenergic agonist (LABA). It works by relaxing the muscles around your airways, making it easier to breathe. Unlike rescue inhalers that you use during a flare-up, Striverdi is a maintenance medication — you take two puffs once a day, every day, at the same time.
It's made by Boehringer Ingelheim and delivered through the Respimat soft mist inhaler, which creates a slow-moving mist that's easier to inhale than some dry powder devices. The typical dose is 5 mcg daily (two inhalations of 2.5 mcg each).
To learn more about this medication's uses and dosing, check out our guide on what Striverdi is, its uses, and what you need to know.
There are several reasons you might struggle to find Striverdi Respimat at your local pharmacy. Here are the most common ones:
Striverdi Respimat is a specialty COPD inhaler, and not every pharmacy keeps it on the shelf. Large chain pharmacies tend to stock the most commonly prescribed inhalers first. Since Striverdi occupies a smaller share of the COPD market compared to combination inhalers like Stiolto Respimat or Spiriva, some pharmacies simply don't carry it regularly.
As of 2026, there is no FDA-approved generic version of Striverdi Respimat. That means there's only one manufacturer (Boehringer Ingelheim) producing it. When supply depends on a single source, any production hiccup — even a minor one — can ripple through the supply chain.
Some insurance plans and pharmacy benefit managers have dropped Striverdi from their preferred formulary lists. For example, certain Express Scripts plans have excluded Striverdi Respimat in favor of other COPD inhalers. When fewer patients fill prescriptions for a particular drug, pharmacies may stop stocking it altogether.
The pharmaceutical supply chain is complex. Even when the manufacturer has adequate supply, distribution bottlenecks — from warehouse delays to shipping issues — can leave specific regions or pharmacies temporarily without stock. Specialty inhalers with unique delivery devices like the Respimat system can be especially vulnerable to these disruptions.
If your pharmacy doesn't have Striverdi in stock, don't panic. Here are some practical steps you can take:
Tools like Medfinder can help you search for pharmacies near you that have Striverdi Respimat in stock right now. Instead of calling pharmacy after pharmacy, you can check availability online in seconds. For a step-by-step walkthrough, read our guide on how to find Striverdi in stock near you.
Independent pharmacies often have more flexibility in what they stock and can sometimes special-order medications faster than large chains. They may also have better relationships with wholesalers that carry specialty inhalers.
If Striverdi is consistently unavailable in your area, your doctor may be able to switch you to a similar medication. Other LABA options for COPD include Arcapta Neohaler (Indacaterol), Serevent Diskus (Salmeterol), or the combination inhaler Stiolto Respimat (Tiotropium/Olodaterol). Learn more about your options in our article on alternatives to Striverdi.
The manufacturer's patient support program may be able to help you locate a pharmacy with stock or connect you with their patient assistance program if cost is also a barrier. Visit patient.boehringer-ingelheim.com for more information.
The cash price for Striverdi Respimat typically ranges from $275 to $400 for a one-month supply. With discount cards from services like GoodRx or SingleCare, you may be able to bring the price down to around $230 to $260. Boehringer Ingelheim also offers a copay savings card for commercially insured patients. For a full breakdown of savings options, see our article on how to save money on Striverdi in 2026.
Finding Striverdi Respimat shouldn't be harder than managing your COPD itself. While supply challenges, formulary changes, and limited stocking can make it frustrating, there are real steps you can take to track down your medication. Start with a tool like Medfinder to check pharmacy availability near you, and don't hesitate to talk to your doctor if you're running into consistent roadblocks.
Your breathing matters. Don't let a stocking issue stand between you and the treatment you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
